Diana Li specializes in mergers & acquisitions, license and commercialization transaction, regulatory and corporate matters, PE/VC and investment for pharmaceutical, biotech, medical device and other healthcare industry clients.  In the China legal market, she is mentioned as leading individual for life sciences by Legal 500 2020 –2025,  as distinguished practitioner in Healthcare legal services by Asia Law 2022-2024, and as up and coming lawyers for healthcare by Chambers and Partners –Greater China through 2020 to 2025.